Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-04-10 5:28 pm Purchase |
2025-04-10 | 13G | Outlook Therapeutics, Inc. OTLK |
Sphera Funds Management Ltd. | 2,571,426 7.490% |
857,142 (+50.00%) |
Filing History |
| 2025-04-10 5:27 pm Purchase |
2025-03-31 | 13G | Skye Bioscience, Inc. SKYE |
Sphera Funds Management Ltd. | 1,476,353 4.770% |
174,835 (+13.43%) |
Filing History |
| 2025-04-10 5:25 pm Sale |
2025-03-31 | 13G | Chemomab Therapeutics Ltd. CMMB |
Sphera Funds Management Ltd. | 900,428 4.780% |
-314,147 (-25.86%) |
Filing History |
| 2025-03-03 3:58 pm Purchase |
2025-01-17 | 13G | Outlook Therapeutics, Inc. OTLK |
Sphera Funds Management Ltd. | 1,714,284 5.210% |
1,714,284 (New Position) |
Filing History |
| 2024-11-04 12:05 pm Purchase |
2024-09-30 | 13G | Jasper Therapeutics, Inc. JSPR |
Sphera Funds Management Ltd. | 189,270 1.250% |
189,270 (New Position) |
Filing History |
| 2024-08-20 2:36 pm Purchase |
2024-07-25 | 13G | Chemomab Therapeutics Ltd. CMMB |
Sphera Funds Management Ltd. | 1,214,575 6.560% |
1,214,575 (New Position) |
Filing History |
| 2024-02-08 09:51 am Purchase |
2024-01-29 | 13G | Skye Bioscience, Inc. SKYE |
Sphera Funds Management Ltd. | 1,301,518 5.390% |
1,301,518 (New Position) |
Filing History |
| 2024-02-05 09:15 am Purchase |
2023-12-31 | 13G | Jasper Therapeutics, Inc. JSPR |
Sphera Funds Management Ltd. | 7,130,625 6.390% |
6,561,912 (+1153.82%) |
Filing History |
| 2024-02-05 09:13 am Sale |
2023-12-31 | 13G | Praxis Precision Medicines, Inc. PRAX |
Sphera Funds Management Ltd. | 328,986 3.740% |
-255,303 (-43.69%) |
Filing History |
| 2024-02-05 09:12 am Sale |
2023-12-31 | 13G | Inozyme Pharma, Inc. INZY |
Sphera Funds Management Ltd. | 1,562,907 2.530% |
-533,351 (-25.44%) |
Filing History |
| 2024-02-05 09:10 am Purchase |
2023-12-31 | 13G | ProMIS Neurosciences, Inc. PMN |
Sphera Funds Management Ltd. | 1,892,474 9.990% |
39,956 (+2.16%) |
Filing History |
| 2023-10-10 11:15 am Purchase |
2023-09-27 | 13G | Jasper Therapeutics, Inc. JSPR |
Sphera Funds Management Ltd. | 568,713 5.130% |
568,713 (New Position) |
Filing History |
| 2023-08-30 09:43 am Purchase |
2023-08-23 | 13G | ProMIS Neurosciences, Inc. PMN |
Sphera Funds Management Ltd. | 1,852,518 9.990% |
1,852,518 (New Position) |
Filing History |
| 2023-06-27 10:01 am Unchanged |
2023-06-16 | 13G | Praxis Precision Medicines, Inc. PRAX |
Sphera Funds Management Ltd. | 584,289 7.350% |
0 (Unchanged) |
Filing History |
| 2023-06-22 11:26 am Purchase |
2023-06-16 | 13G | Praxis Precision Medicines, Inc. PRAX |
Sphera Funds Management Ltd. | 584,289 7.310% |
584,289 (New Position) |
Filing History |
| 2023-03-07 06:01 am Purchase |
2023-03-03 | 13G | Inozyme Pharma, Inc. INZY |
Sphera Funds Management Ltd. | 2,096,258 5.190% |
2,096,258 (New Position) |
Filing History |
| 2023-02-06 11:27 am Sale |
2022-12-31 | 13G | Cyclacel Pharmaceuticals, Inc. CYCC |
Sphera Funds Management Ltd. | 16,667 1.990% |
-17,221 (-50.82%) |
Filing History |
| 2022-02-14 06:15 am Purchase |
2021-12-31 | 13G | Cyclacel Pharmaceuticals, Inc. CYCC |
Sphera Funds Management Ltd. | 33,888 5.100% |
100 (+0.30%) |
Filing History |
| 2022-02-14 06:13 am Sale |
2021-12-31 | 13G | Altimmune, Inc. ALT |
Sphera Funds Management Ltd. | 1,244,241 3.130% |
-2,531,377 (-67.05%) |
Filing History |
| 2021-08-31 11:03 am Purchase |
2021-08-26 | 13G | Altimmune, Inc. ALT |
Sphera Funds Management Ltd. | 3,775,618 8.840% |
3,775,618 (New Position) |
Filing History |